Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
doi:10.1038/sj.ijo.0802783.
SURMOUNT-1 showed 19.5% average weight loss at this dose
The SELECT trial (2023) demonstrated that Wegovy significantly reduces major adverse cardiovascular events (MACE) heart attack, stroke, cardiovascular death in patients with established cardiovascular disease and obesity
The drugs have similar side effects to the injectables, including nausea and diarrhea
Prioritize protein (0.7 to 1.0 grams per pound of target body weight), eat frequent small meals rather than large infrequent ones, limit high-fat foods during dose increases to reduce nausea, stay hydrated, and avoid alcohol (which worsens both GI side effects and calorie intake)
Tias Metabolic Health & Weight Loss Program is built specifically for this evaluation: a womens-focused program that includes comprehensive metabolic screening, hormonal assessment, and medically supervised access to GLP-1 medications when clinically indicated with ongoing monitoring and long-term follow-up, not a one-time prescription
